Latest Grifols News & Updates

See the latest news and media coverage for Grifols. We track all announcements, press releases, and industry mentions in real time, all in one place.

Grifols

Global healthcare company focused on plasma-derived medicines and diagnostics

grifols.com

Headquarters: Sant Cugat del Vallès, Spain
Founded year: 1909
Company type: Public company
Number of employees: 10,000+
Industry: Pharmaceuticals

Last updated Today

Latest news about Grifols

In short: Grifols reorganized its US business structure, initiated multiple Phase 3 clinical trials, and faced media scrutiny over donor safety.

Company announcements

July 30 Grifols

Grifols appoints new board member after resignation

Joanna Susan Le Couilliard replaces Iñigo Sánchez-Asiaín Mardones as independent director and Audit Committee Chair

July 28 Grifols

Grifols reported solid first half 2026 results

Revenue grew from immunoglobulins, debt refinanced, organizational transformation advanced.

July 28 Grifols

Grifols reports 2.6% revenue growth and 28.7% net profit rise

Adjusted EBITDA reached €854 million with margin improvement, and free cash flow pre-M&A turned positive to €91 million.

July 16 Grifols

Grifols doses first patients in two Phase 3 immunoglobulin trials

SIGMA evaluates GAMUNEX-C in secondary immunodeficiency patients with blood cancers; XPERT tests XEMBIFY's non-inferiority to GAMUNEX-C for CIDP.

Media coverage

July 26 El Confidencial

The Grifols break free from Brookfield vulture fund and renew debt with Botín and BofA

Scranton Enterprises, the holding company of the Grifols family and several executives of the Catalan pharmaceutical company, renews a key credit of 456 million with...

July 25 MSN

Grifols sacrifices short-term profitability to gain efficiency: the closure of centers in the US takes its toll before boosting margins

Grifols faces a transition quarter. The pharmaceutical company will see how the closure of 29 plasma centers in the US reduces its short-term...

July 25 Ad hoc news

Grifols stock steadies as leverage reduction and earnings trends shape investor focus

Grifols stock reflects a balance between ongoing debt reduction and recent earnings trends, with leverage and margins remaining central to the investment story for the...

July 22 EL MUNDO

Grifols soars on the stock market more than 7% after presenting half-year results and clearing the "three big concerns" of investors.

The blood plasma multinational Grifols records, from the opening bell and by mid-session, the biggest rise on the Stock Exchange of...

Never miss news about Grifols

Track Grifols and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.